Targeting of a Conformationally Exposed, Tumor-Specific Epitope of EGFR as a Strategy for Cancer Therapy
Hui K Gan, Antony W Burgess, Andrew HA Clayton, Andrew M Scott
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2012
Awarded by National Health and Medical Research Council
Awarded by Victorian Cancer Agency
A.W. Burgess and A. M. Scott are inventors on mAb806 patents. A. M. Scott has received funding from the Ludwig Institute for Cancer Research and from Abbott Pharmaceuticals and has served as a consultant for Life Science Pharmaceuticals. No potential conflicts of interest were reported by the other authors.National Health and Medical Research Council (487922); Operational Infrastructure Support, Victorian Government; Victorian Cancer Agency grant (CRF10-16 to H.K. Gan).